PharmaDrug is restructuring approximately $1 million in debt in the form of convertible debentures.
Articles
ATAI Life Sciences acquiring Kures to develop novel therapeutics for opioid abuse
Atai Life Sciences is bolstering its R&D platform with the acquisition of New York-based Kures.
Psychedelics Investing 101: Past and Current Psychedelic Drug Clinical Studies
Psychedelic drug R&D is ramping up rapidly. The number of past and current clinical studies on these substances will surprise you.
Legalizing Medicinal Use of Psilocybin on Oregon’s November Ballot
Oregon could become the first U.S. state to LEGALIZE the (medicinal) use of a psychedelic drug.
Psychedelics Investing 101: the Drug Approval Process and Drug Patents
Understanding the drug approval process that leads to drug patents and drug licensing is of critical importance for successful investing in psychedelics.
Osoyoos Provides Corporate Update on AI Pharma Acquisition
Osoyoos Cannabis provides additional details on its previously announced acquisition.
Mydecine Innovations Group Adds 7-Time Nobel Peace Prize Nominee Dr. M.S Reddy to Its Scientific Advisory Board
Mydecine's new Scientific Advisor holds over 150 U.S. and international patents and will oversee Mydecine's mycology lab.
Mydecine Adds Biotech Heavy-Hitter To Science Team
Mydecine Innovations Group has added one of the world's pre-eminent biotech scientists to its Scientific Advisory Board.
IntelGenx and Cybin Corp Enter Into Feasibility Agreement for Fast-Acting, Orally-Dissolving Psilocybin Film
Cybin Corp is partnering with IntelGenx Corp to produce a new delivery system for pharmaceutical-grade psilocybin.
The Psychedelics Revolution: From ‘War on Drugs’ To Funding Psychedelic Drug Research
The Psychedelics Revolution. One part changing social attitudes. One part medical necessity. One part hard economics.
Looking For The Perfect Inflation Hedge? Try This Company
Inflation is rapidly eroding our purchasing power and consuming our wealth. Here is a powerful antidote for investors.
Hinterland to Acquire Novamind Ventures Inc
Novamind Ventures Inc. is preparing to go public via amalgamation with unlisted public company, Hinterland Metals Inc.
CannaGlobal, Sansero Life Sciences and Rise Wellness To Merge, Creating a New International Psychedelics Company
Three private companies are merging to create a new entity in the psychedelics space.
Red Light Holland Names Medical and Scientific Division
Red Light Holland makes move into medicinal psychedelic applications.
MPV Exploration Inc. Announces Definitive Agreement for Amalgamation with Entheon Biomedical Corp and Financing
Entheon Biomedical announces a three-cornered amalgamation with MPV Exploration along with concurrent financing.